Global Genetic Vaccine 麻豆原创 Research Report 2023

Publication ID:

PB504231519

Publication Date:

April 20, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
Highlights
The global Genetic Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Genetic Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genetic Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Genetic Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genetic Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetic Vaccine.
The Genetic Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genetic Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genetic Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Segment by Type
Recombinant Protein Vaccine
Gene-Based Vaccine
Segment by Application
Human
Animal
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Genetic Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Genetic Vaccine 麻豆原创 Overview
1.1 Product Overview and Scope of Genetic Vaccine
1.2 Genetic Vaccine Segment by Type
1.2.1 Global Genetic Vaccine 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Genetic Vaccine Segment by Application
1.3.1 Global Genetic Vaccine 麻豆原创 Value by Application: (2023-2029)
1.3.2 Human
1.3.3 Animal
1.4 Global Genetic Vaccine 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Genetic Vaccine Revenue 2018-2029
1.4.2 Global Genetic Vaccine Sales 2018-2029
1.4.3 Global Genetic Vaccine 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Genetic Vaccine 麻豆原创 Competition by Manufacturers
2.1 Global Genetic Vaccine Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Genetic Vaccine Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Genetic Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Genetic Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Genetic Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Genetic Vaccine, Product Type & Application
2.7 Genetic Vaccine 麻豆原创 Competitive Situation and Trends
2.7.1 Genetic Vaccine 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Genetic Vaccine Players 麻豆原创 Share by Revenue
2.7.3 Global Genetic Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Genetic Vaccine Retrospective 麻豆原创 Scenario by Region
3.1 Global Genetic Vaccine 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Genetic Vaccine Global Genetic Vaccine Sales by Region: 2018-2029
3.2.1 Global Genetic Vaccine Sales by Region: 2018-2023
3.2.2 Global Genetic Vaccine Sales by Region: 2024-2029
3.3 Global Genetic Vaccine Global Genetic Vaccine Revenue by Region: 2018-2029
3.3.1 Global Genetic Vaccine Revenue by Region: 2018-2023
3.3.2 Global Genetic Vaccine Revenue by Region: 2024-2029
3.4 North America Genetic Vaccine 麻豆原创 Facts & Figures by Country
3.4.1 North America Genetic Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Genetic Vaccine Sales by Country (2018-2029)
3.4.3 North America Genetic Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Genetic Vaccine 麻豆原创 Facts & Figures by Country
3.5.1 Europe Genetic Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Genetic Vaccine Sales by Country (2018-2029)
3.5.3 Europe Genetic Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Genetic Vaccine 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Genetic Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Genetic Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Genetic Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Genetic Vaccine 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Genetic Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Genetic Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Genetic Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Genetic Vaccine 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Genetic Vaccine 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Genetic Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Genetic Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Genetic Vaccine Sales by Type (2018-2029)
4.1.1 Global Genetic Vaccine Sales by Type (2018-2023)
4.1.2 Global Genetic Vaccine Sales by Type (2024-2029)
4.1.3 Global Genetic Vaccine Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Genetic Vaccine Revenue by Type (2018-2029)
4.2.1 Global Genetic Vaccine Revenue by Type (2018-2023)
4.2.2 Global Genetic Vaccine Revenue by Type (2024-2029)
4.2.3 Global Genetic Vaccine Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Genetic Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Genetic Vaccine Sales by Application (2018-2029)
5.1.1 Global Genetic Vaccine Sales by Application (2018-2023)
5.1.2 Global Genetic Vaccine Sales by Application (2024-2029)
5.1.3 Global Genetic Vaccine Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Genetic Vaccine Revenue by Application (2018-2029)
5.2.1 Global Genetic Vaccine Revenue by Application (2018-2023)
5.2.2 Global Genetic Vaccine Revenue by Application (2024-2029)
5.2.3 Global Genetic Vaccine Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Genetic Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Genetic Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Genetic Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Genetic Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Zoties
6.4.1 Zoties Corporation Information
6.4.2 Zoties Description and Business Overview
6.4.3 Zoties Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zoties Genetic Vaccine Product Portfolio
6.4.5 Zoties Recent Developments/Updates
6.5 Elanco
6.5.1 Elanco Corporation Information
6.5.2 Elanco Description and Business Overview
6.5.3 Elanco Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Elanco Genetic Vaccine Product Portfolio
6.5.5 Elanco Recent Developments/Updates
6.6 Boehringer-Ingelheim
6.6.1 Boehringer-Ingelheim Corporation Information
6.6.2 Boehringer-Ingelheim Description and Business Overview
6.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer-Ingelheim Genetic Vaccine Product Portfolio
6.6.5 Boehringer-Ingelheim Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Indian Immunologicals Genetic Vaccine Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
6.8 Plumbline Life Sciences
6.8.1 Plumbline Life Sciences Corporation Information
6.8.2 Plumbline Life Sciences Description and Business Overview
6.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Plumbline Life Sciences Genetic Vaccine Product Portfolio
6.8.5 Plumbline Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Genetic Vaccine Industry Chain Analysis
7.2 Genetic Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Genetic Vaccine Production Mode & Process
7.4 Genetic Vaccine Sales and 麻豆原创ing
7.4.1 Genetic Vaccine Sales Channels
7.4.2 Genetic Vaccine Distributors
7.5 Genetic Vaccine Customers
8 Genetic Vaccine 麻豆原创 Dynamics
8.1 Genetic Vaccine Industry Trends
8.2 Genetic Vaccine 麻豆原创 Drivers
8.3 Genetic Vaccine 麻豆原创 Challenges
8.4 Genetic Vaccine 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.